MSB 3.21% $1.13 mesoblast limited

FDA ODAC Meeting Material discussion analysis, page-357

  1. 5,487 Posts.
    lightbulb Created with Sketch. 8943
    FDA rejected those claims by MSB when they checked the data submitted for the trial.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.